Variation in postoperative radiotherapy delivery for patients with screen-detected breast cancer in the south Thames (east) Region

Clinical Oncology : a Journal of the Royal College of Radiologists
J C Goy, H J Dobbs

Abstract

This paper stems from a region-wide audit of postoperative radiotherapy treatment for patients with screen-detected breast cancer, commencing from the start of the South Thames (East) screening programme in June 1988 and ending in March 1992. It reports on the variation in treatment practices amongst clinical oncologists in the region. There was diversity in treatment schedules, dose specification points, and the use of lymph node radiotherapy, breast boost and interstitial implants. While local protocols vary by centre and individual oncologist, many treatment decisions appear to have been dictated by the availability of machines and other resources. However, further analysis suggests that the variation is within the same range as that described in the nationwide survey of breast radiotherapy by the Audit Office of the Royal College of Radiologists in 1995 [1-3].

References

Jul 1, 1992·Journal of Clinical Pathology·H Jones, T Clarke
Dec 1, 1993·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·T Landberg, M Nilsson

❮ Previous
Next ❯

Citations

Jul 13, 2000·International Journal of Radiation Oncology, Biology, Physics·W ShelleyW Mackillop
Oct 16, 2004·The British Journal of Radiology·J A Violet, C Harmer
Apr 1, 2008·International Journal of Radiation Oncology, Biology, Physics·Carolyn W TaylorSarah C Darby
Aug 15, 2000·Clinical Oncology : a Journal of the Royal College of Radiologists·D B Landau, R W Laing
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer L MalinRobert H Brook
May 31, 2001·Australasian Radiology·G DelaneyR O Centre
Sep 4, 2008·Plastic and Reconstructive Surgery·Nicholas W ClavinBabak J Mehrara

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
I A OlivottoV E Basco
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
H Pourquier
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
Marie-Luise Sautter-BihlHans Ulrich Ulmer
© 2022 Meta ULC. All rights reserved